У нас вы можете посмотреть бесплатно ATTENTION results: endovascular therapy vs. best medical management for basilar artery occlusion или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Raul Nogueira, MD, University of Pittsburgh, Pittsburgh, PA, shares the anticipated findings of the randomized, controlled ATTENTION trial (NCT04751708), assessing the safety and efficacy of endovascular treatment for acute basilar artery occlusion (BAO), compared to best medical management (BMM). In total, 340 patients with acute ischemic stroke with basilar artery occlusion were recruited and followed up for 90 days. The primary outcome of the trial was a favorable outcome, defined as a modified Rankin scale score of 0-3. There was a significant difference in favorable outcomes in the thrombectomy group compared to BMM (46% vs. 24%), as well as a lower degree of overall disability, lower mortality rate, and more patients achieving independence. A significant increase in the rate of symptomatic intercranial hemorrhage with endovascular treatment was reported, compared to BMM. This interview took place at European Stroke Organisation Conference 2022 in Lyon, France.